Human DLL4 Antibody (Navicixizumab, Research Use)

产品名称	Human DLL4 Antibody (Navicixizumab, Research Use)
目录号	NBR-0163
别名	Hdelta2; Delta; AOS6
外观	Transparent Liquid
分子量	150kDa
CAS	N/A
溶解度	Water, PBS, TBS Buffer,etc.
存储条件	Temp. -80℃
保存时间	see COA
备注1	CHO Expressed
备注2	Ab. Isotype - IgG

目录号	规格	价格	库存状态
NBR-0163-100UG	100ug	￥550	请咨询
NBR-0163-1MG	1mg	￥3500	请咨询
NBR-0163-5MG	5mg	￥7500	请咨询

【产品概况】

产品名称：Human DLL4 Antibody (Navicixizumab, Research Use)
产品编号：NBR-0163
针对靶点：DLL4
抗体药商品名：Navicixizumab
抗体药描述：Navicixizumab is an anti-DLL4/VEGF bispecific antibody product candidate that demonstrated antitumor activity in patients who were previously treated with Avastin® (bevacizumab) in a Phase 1b clinical trial.

【产品参数】

产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

【基因信息】

Gene Name: DLL4
Synonyms: Hdelta2; Delta; AOS6
Target Description: DLL4 (Delta Like Canonical Notch Ligand 4) is a Protein Coding gene. Diseases associated with DLL4 include Adams-Oliver Syndrome 6 and Adams-Oliver Syndrome. Among its related pathways are NOTCH2 Activation and Transmission of Signal to the Nucleus and Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants. Gene Ontology (GO) annotations related to this gene include calcium ion binding and Notch binding.
Ensembl: ENSG00000128917
Uniprot: Q9NR61